Issue 4/2015
Content (18 Articles)
Tamoxifen and risk of contralateral breast cancer among women with inherited mutations in BRCA1 and BRCA2: a meta-analysis
Lingyun Xu, Yansheng Zhao, Zhiqiang Chen, Yujiao Wang, Lin Chen, Shui Wang
Phase II clinical trial of metronomic chemotherapy with combined irinotecan and tegafur–gimeracil–oteracil potassium in metastatic and recurrent breast cancer
Hiroko Otsuka, Teruhiko Fujii, Uhi Toh, Nobutaka Iwakuma, Ryuji Takahashi, Mai Mishima, Miki Takenaka, Tatsuyuki Kakuma, Maki Tanaka, Kazuo Shirouzu
Applicability of two different validated models to predict axillary non-sentinel lymph node status by sentinel node biopsy in a single Italian center
Serena Bertozzi, Ambrogio P. Londero, Francesco Giacomuzzi, Vito Angione, Arnalda Carbone, Roberto Petri, Sergio Bernardi
MRI and ultrasound evaluation of invasive lobular carcinoma of the breast after primary systemic therapy
Miki Mori, Hiroko Tsunoda, Yayoi Takamoto, Michiko Murai, Mari Kikuchi, Satoshi Honda, Koyu Suzuki, Hideko Yamauchi
C4.4A highly expressed in HER2-positive human breast cancers may indicate a good prognosis
Tomohiro Miyake, Takashi Ito, Ayako Yanai, Natsuko Inoue, Yoshimasa Miyagawa, Keiko Murase, Michiko Imamura, Shigetoshi Ichii, Yuichi Takatsuka, Tomoyuki Nishizaki, Seiichi Hirota, Masahisa Ohtsuka, Hirofumi Yamamoto, Shinzaburo Noguchi, Yasuo Miyoshi
Comparison of the clinicopathological features of invasive ductal, invasive lobular, and mixed (invasive ductal + invasive lobular) carcinoma of the breast
Baha Zengel, Ulkem Yararbas, Ali Duran, Adam Uslu, Nukhet Elıyatkın, Mehmet Ali Demırkıran, Fevzi Cengiz, Cenk Şimşek, Hakan Postacı, Enver Vardar, Raika Durusoy
Equol as a potent radiosensitizer in estrogen receptor-positive and -negative human breast cancer cell lines
Bita Taghizadeh, Laleh Ghavami, Alireza Nikoofar, Bahram Goliaei
What we should know in mammography after reduction mammoplasty and mastopexy?
Hanna Kim, Bong Joo Kang, Sung Hun Kim, Hyeon Sook Kim, Eun Suk Cha
Association of body mass index with risk of luminal A but not luminal B estrogen receptor-positive and HER2-negative breast cancer for postmenopausal Japanese women
Yoshimasa Miyagawa, Tomohiro Miyake, Ayako Yanai, Keiko Murase, Michiko Imamura, Shigetoshi Ichii, Yuichi Takatsuka, Takashi Ito, Seiichi Hirota, Masaru Saito, Yoshinao Kotoura, Keisuke Miyauchi, Yasuhisa Fujimoto, Takuya Hatada, Mitsunori Sasa, Yasuo Miyoshi
The value of progesterone receptor expression in predicting the Recurrence Score for hormone-receptor positive invasive breast cancer patients
Toshinao Onoda, Hideko Yamauchi, Hiroshi Yagata, Koichiro Tsugawa, Naoki Hayashi, Atsushi Yoshida, Koyu Suzuki, Osamu Sakurai, Seigo Nakamura
Thioglucose-bound gold nanoparticles increase the radiosensitivity of a triple-negative breast cancer cell line (MDA-MB-231)
Cuihong Wang, Yuhua Jiang, Xiaohong Li, Likuan Hu
How do surgeons approach breast cancer surgery in Turkey? A national survey
Mustafa Emiroğlu, Abdullah Inal, İsmail Sert, Enver İlhan, Kemal Peker, Mehmet Ali Gürçelik, Hilmi Güngör, Semra Salimoğlu, Didem Can, Hülya Ellidokuz, Cengiz Aydın
Erratum to: How do surgeons approach breast cancer surgery in Turkey? A national survey
Mustafa Emiroğlu, Abdullah Inal, İsmail Sert, Enver İlhan, Kemal Peker, Mehmet Ali Gulcelik, Hilmi Güngör, Semra Salimoğlu, Didem Can, Hülya Ellidokuz, Cengiz Aydın
Ductal carcinoma in situ arising in tubular adenoma of the breast
Michiyo Saimura, Keisei Anan, Shoshu Mitsuyama, Minoru Ono, Satoshi Toyoshima
HER-2 positive primary solid neuroendocrine carcinoma of the breast: a case report and review of the literature
Guler Yavas, Pinar Karabagli, Murat Araz, Cagdas Yavas, Ozlem Ata
Two cases of primary small cell carcinoma of the breast showing non-mass-like pattern on diagnostic imaging and histopathology
Maki Amano, Kanako Ogura, Yutaka Ozaki, Mitsukuni Tamai, Toshiaki Kitabatake, Minoru Fujisawa, Kuniaki Kojima
Use of indocyanine green alone for sentinel node biopsy in breast cancer
D. Samorani, T. Fogacci, L. Dellachiesa